ProBion is state-of-the-art probiotic customised for improving digestion for all ages including infants. Expertly chosen strains create harmonising effect, and guaranteed potency produces therapeutic results
We choose strains with proven benefits supported by hundreds of peer-reviewed studies, and we combine them in a matrix with patented technology to ensure their safe passage to the gut where they can alleviate digestive disorders
ProBion Clinica's positive probiotic effect was verified in a 2017 clinical study involving humans with colon problems. We also have 25 years of dose-response research, with efficacy of our probiotics validated by independent labs.
The ProBion freeze dry, low-compression technique produces a unique dry tablet free from damage by oxygen and humidity. Bacteria slow-released into the gut, allowing greatest sustainability, deposition and activation.
Vigorous cultures protected and delivered to the gut help healthy flora thrive and ensure that they outnumber harmful bacteria, building the foundation for eliminating digestive disorders
Our bacteria strains are clinically chosen and combined by Swedish scientists to target different digestive conditions, including intestinal motility that is too slow or too rapid, or is too sensitive causing irregularity. The strains harmonise with each other and are safe and effective for everyone irrespective of age and sex.
ProBion delivers vigorous healthy bacteria to the gastrointestinal tract with controlled release over 150-180 minutes, enabling 10 times as much deposition and activation of live cultures compared to conventional probiotic capsules
Analysed by independent labs using Flow Cytometric Fluorescence technique with FISH and FC analyses, our probiotics have the viability, bacteria integrity and quality assurance needed for clinical trials.
Our dry tablets have 2.5 years shelf life without need for refrigeration, with 10 times superior sustainability compared to conventional capsules. Lab analyses show the majority of beneficial bacteria remain undamaged at expiry date. Clinical study further shows the bacteria can remain viable in the small and large intestines where they product therapeutic effects.
We select strains that are resistant to gastric and bile acids. They are nourished by inulin prebiotics and dietary fibres, and protected by mucous-forming molecules of xanthan which shelter the bacteria and provide them with a safe passage through the gastrointestinal tract.
The unique structure of this ingenious tablet form is produced with a low-compression freeze dry technology where less than 10% of the conventional compression force is used. This ensures the greatest viability of the cultures during and after production. Bacteria embedded into the matrix are protected from damage by oxygen and humidity.
Developed by Wasa Medicals AB in Sweden, ProBion dry tablets were used in a 2017 human clinical study aimed at ascertaining the effect of probiotics on gut bacteria in colon cancer patients. It was found that two tablets of ProBion Clinical a day for an average of 31 days (range: 8 to 78 days) had wiped out a significant amount of cancer-associated harmful bacteria, and generated a plethora of beneficial bacteria with anti-inflammatory effects. The conclusion showed promise for using probiotics to mitigate dysbiosis and improve gut health for cancer prevention. It also showed that ProBion tablets were able to deliver and sustain undamaged probiotic bacteria in the large intestines to achieve therapeutic effect. BUY PROBION NOW
Wasa Medicals AB, based in Halmstad, Sweden, is a member of the International Probiotic Association (IPA). Led by CEO Lennart Cedgard, MD, the company developed the ProBion dry tablet matrix through collaboration with Swedish doctors and scientists, and has continuously researched probiotic dosage effect for 25 years. Dr Cedgard, who earned his medical degree from Gothenburg University Institute of Medicine, has been a general practitioner since 1982. With over 35 years clinical experience in intestinal micro-ecology, Dr Cedgard is a contributor of papers on probiotics and microbiology to medical journals. In 2016 he co-founded ProBion Innovation Sweden AB (PISA), a biotechnology research company, to study innovative use of probiotics for alleviating diseases. LEARN MORE ABOUT PISA
Probiotics serve to restore the balance of our intestinal bacteria. While promoting the growth of beneficial bacterial, they will also cause the dying off of harmful bacteria. This is a process of detoxification that can lead to healing crises in the form of intestinal discomfit and other symptoms associated to chronic health issues during the first 2-3 weeks. These symptoms will pass as the body adjusts to healthy gut flora, leading to long-term health improvement.
Excellent product. I suffer from IBS and diverticular disease and these tablets have improved my digestive system tremendously. I would definitely recommend these and will be purchasing probion again soon.
They are well worth the price compared to less effective products on the market. These actually work! I’ve taken Probion for years now and I couldn’t be without it. I can highly recommend it.
I overdose probiotics on a regular basis - take 4-5 different brands at the time. ProBion is one of them. Overall health and wellbeing, digestion and the energy level are fantastic. I feel amazing.
I've had a bad stomach for more than 40 years! All my IBS problems were gone when I started taking ProBion Clinica a couple of years ago. For the first time in my life I could do number two without pain!